We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MRVI market cap is 524.6M. The company's latest EPS is USD -0.5688 and P/E is -3.64.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 64.18M | 74.6M | 65.38M | 58.25M | 46.85M |
| Operating Income | -18.86M | -9.51M | -169.11M | -36.91M | -49.16M |
| Net Income | -12.08M | -7.59M | -99.04M | -26.15M | -29.95M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 303.1M | 810.49M | 890.8M | 292.23M | 262.4M |
| Operating Income | 119.9M | 554.65M | 574.22M | -31.65M | -235.62M |
| Net Income | 88.97M | 182.04M | 220.21M | -119.03M | -144.85M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.44B | 1.45B | 1.28B | 1.01B | 959.75M |
| Total Liabilities | 667.25M | 671.19M | 665.09M | 431.04M | 429.48M |
| Total Equity | 777.39M | 776.41M | 613.13M | 577.21M | 530.27M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.27B | 1.92B | 2.28B | 1.49B | 1.01B |
| Total Liabilities | 1.12B | 1.37B | 1.38B | 697.57M | 431.04M |
| Total Equity | 154.75M | 545.36M | 905.24M | 789.88M | 577.21M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.47M | 8.97M | 22.1M | 7.47M | -9.39M |
| Investing | -4.24M | -10.43M | -19.39M | -24.32M | -23.13M |
| Financing | -560k | -332k | 477k | -235.71M | -4.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 152.19M | 368.57M | 535.98M | 126.22M | 7.47M |
| Investing | 6.07M | 105.66M | -267.61M | -122.31M | -24.32M |
| Financing | 53.21M | -159.05M | -187.5M | -61.09M | -235.71M |
| Market Cap | 524.6M |
| Price to Earnings Ratio | -3.64 |
| Price to Sales Ratio | 2.01 |
| Price to Cash Ratio | 1.64 |
| Price to Book Ratio | 0.91 |
| Dividend Yield | - |
| Shares Outstanding | 254.66M |
| Average Volume (1 week) | 1.34M |
| Average Volume (1 Month) | 1.54M |
| 52 Week Change | -70.49% |
| 52 Week High | 10.03 |
| 52 Week Low | 1.665 |
| Spread (Intraday) | 0.24 (10.76%) |
| Company Name | Maravai LifeSciences Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
